Gene Therapy Immunogenicity - Virtual Summit

Conference themes
Immunogenicity compromises both the efficacy and safety of gene therapies and thus represents one of the most prominent challenges that must be overcome in the field. Uniting translational, clinical, regulatory and manufacturing gene therapy functions, the inaugural Gene Therapy Immunogenicity Summit is the industry's definitive meeting enabling you to better measure, modulate and predict immune response and drive transformative treatments through the clinic to patients

Professional congress organizer (PCO)
Hanson Wade

Notes
URL:
Brochure: https://go.evvnt.com/614539-3?pid=4832

Speakers: Barry Byrne, Professor and Associate Chairman, University of Florida, Mark Milton, Area Head of Ophthalmology, Novartis, Sander van Deventer, Executive Vice President, uniQure and more.

https://go.evvnt.com/614539-2?pid=4832

Mr. Customer Service